Frequent amplification of chromosomal region 20q12-q13 in ovarian cancer.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Clinical Cancer Research

• Publication date

  2000-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 10815905
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone.

  1999cited by this paper
• Molecular genetic characterization of BRCA1- and BRCA2-linked hereditary ovarian cancers.

  1998cited by this paper
• Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation

  1998cited by this paper
• In breast cancer, amplification of the steroid receptor coactivator gene AIB1 is correlated with estrogen and progesterone receptor positivity.

  1998cited by this paper
• Tissue microarrays for high-throughput molecular profiling of tumor specimens

  1998cited by this paper
• Molecular cytogenetics of primary breast cancer by CGH

  1998cited by this paper
• Genetic changes in inherited and sporadic ovarian carcinomas by comparative genomic hybridization: extensive similarity except for a difference at chromosome 2q24-q32.

  1998cited by this paper
• Positional cloning of ZNF217 and NABC1: genes amplified at 20q13.2 and overexpressed in breast carcinoma.

  1998influential reference
• Distinct somatic genetic changes associated with tumor progression in carriers of BRCA1 and BRCA2 germ-line mutations.

  1997cited by this paper
• Increased copy number at 17q22‐q24 by CGH in breast cancer is due to high‐level amplification of two separate regions

  1997cited by this paper
• Comparative genomic hybridization detects frequent overrepresentation of chromosomal material from 3q26, 8q24, and 20q13 in human ovarian carcinomas

  1997cited by this paper
• AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer.

  1997cited by this paper
• Tumour biological features of BRCA1-induced breast and ovarian cancer.

  1997cited by this paper
• Overrepresentation of 3q and 8q material and loss of 18q material are recurrent findings in advanced human ovarian cancer

  1996cited by this paper
• DNA amplifications at 20q13 and MDM2 define distinct subsets of evolved breast and ovarian tumours.

  1996cited by this paper
• Hybrid selection of transcribed sequences from microdissected DNA: isolation of genes within amplified region at 20q11-q13.2 in breast cancer.

  1996cited by this paper
• Independent amplification and frequent co-amplification of three nonsyntenic regions on the long arm of chromosome 20 in human breast cancer.

  1996influential reference
• Genetic changes in ovarian cancer.

  1995cited by this paper
• A physical map of chromosome 20 established using fluorescence in situ hybridization and digital image analysis.

  1995cited by this paper
• Genetic analysis of benign, low-grade, and high-grade ovarian tumors.

  1995cited by this paper
• Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors

  1994cited by this paper
• Overexpression of the protein tyrosine phosphatase PTP1B in human breast cancer: association with p185c-erbB-2 protein expression.

  1994cited by this paper
• Identification of cryptic sites of DNA sequence amplification in human breast cancer by chromosome microdissection

  1994cited by this paper
• Overexpression of the tyrosine phosphatase PTP1B is associated with human ovarian carcinomas.

  1994cited by this paper
• Immunohistochemical determination of estrogen and progesterone receptors in human breast carcinoma. Correlation with histopathology and dna flow cytometry

  1990cited by this paper
• Estrogen and Progesterone Receptor Analyses in More Than 4000 Human Breast Cancer Samples: A Study with Special Reference to Age at diagnosis and stability of analyses

  1990cited by this paper
• Steroid receptors and Ki‐67 reactivity in ovarian cancer and in normal ovary: Correlation with dna flow cytometry, biochemical receptor assay, and patient survival

  1990cited by this paper
• Estrogen and progesterone receptor analyses in more than 4,000 human breast cancer samples. A study with special reference to age at diagnosis and stability of analyses. Southern Swedish Breast Cancer Study Group.

  1990cited by this paper

• C20orf27 regulates colorectal cancer growth and metastasis based on different lipid levels.

  2025cites this paper
• Hypoxic HPV‐Positive Cancer Cells Are Particularly Sensitive to the Pro‐Senescent Effects of B‐MYB Repression Due to the Lack of Compensatory A‐MYB Induction

  2025cites this paper
• Claudin-4 Stabilizes the Genome via Nuclear and Cell-Cycle Remodeling to Support Ovarian Cancer Cell Survival

  2024cites this paper
• The Impact of Centrosome Pathologies on Ovarian Cancer Development and Progression with a Focus on Centrosomes as Therapeutic Target.

  2024cites this paper
• From modulation of cellular plasticity to potentiation of therapeutic resistance: new and emerging roles of MYB transcription factors in human malignancies

  2023cites this paper
• Evaluation of He4 Use in the Diagnosis of Ovarian Cancer: First and Second Recurrence, and an Analysis of HE4 Concentration during Second- and Third-Line Chemotherapy

  2023cites this paper
• RNA biomarkers from proximal liquid biopsy for diagnosis of ovarian cancer

  2022cites this paper
• Novel, highly potent PROTACs targeting AURORA-A kinase

  2022cites this paper
• Immune Landscape and an RBM38-Associated Immune Prognostic Model with Laboratory Verification in Malignant Melanoma

  2022cites this paper
• MYBL2 accelerates epithelial-mesenchymal transition and hepatoblastoma metastasis via the Smad/SNAI1 pathway.

  2022cites this paper
• Increased copy number of imprinted genes in the chromosomal region 20q11-q13.32 is associated with resistance to antitumor agents in cancer cell lines

  2022influential citation
• PROGNOSTIC VALUE OF TOPOISOMERASE 2-ALPHA AND B-MYB IN EARLY BREAST CANCER TREATED WITH ADJUVANT CHEMOTHERAPY

  2021cites this paper
• MYB oncoproteins: emerging players and potential therapeutic targets in human cancer

  2021cites this paper
• SRC-3, a Steroid Receptor Coactivator: Implication in Cancer

  2021cites this paper
• Ubiquitin Proteasome Pathway Transcriptome in Epithelial Ovarian Cancer

  2021cites this paper
• Targeting AURKA by microRNA-490-3p suppresses gastric cancer cell growth.

  2021cites this paper
• RNA Binding Protein RNPC1 Promotes Gastric Cancer Progression via Stabilizing the Aurora Kinase B mRNA

  2021cites this paper
• Overexpression of MYBL2 predicts poor prognosis and promotes oncogenesis in endometrial carcinoma

  2021cites this paper
• NCOA3 as a critical oncogene in Thyroid cancer via modulating major signaling pathways

  2021cites this paper
• Association between B-Myb proto-oncogene and the development of malignant tumors

  2021cites this paper
• RNA-binding protein RNPC1 acts as an oncogene in gastric cancer by stabilizing Aurora kinase B mRNA.

  2021cites this paper
• HE4 Overexpression by Ovarian Cancer Promotes a Suppressive Tumor Immune Microenvironment and Enhanced Tumor and Macrophage PD-L1 Expression

  2021cites this paper
• RBM38 in cancer: role and mechanism

  2020cites this paper
• The Role of the Meiotic Component in Reproduction of B-RAF-Mutated Melanoma: A Review and “Brainstorming” Session

  2020cites this paper
• Targeting DNA damage response kinases in cancer therapy.

  2020cites this paper
• Aurora kinases and DNA damage response.

  2020cites this paper
• The phosphatase PTPN1/PTP1B is a candidate marker of better chemotherapy response in metastatic high‐grade serous carcinoma

  2020cites this paper
• RBM38 in cancer: role and mechanism

  2020cites this paper
• PROTAC-mediated degradation reveals a non-catalytic function of AURORA-A kinase

  2020influential citation
• Role of the PI3K/AKT/mTOR signaling pathway in ovarian cancer: Biological and therapeutic significance.

  2019cites this paper
• AU-rich element-binding proteins in colorectal cancer

  2019cites this paper
• ALTERATION IN PROTEIN EXPRESSION OF AURORA A, FHIT AND IGF2 IN ESOPHAGEAL CANCER

  2019cites this paper
• Disruption of the Rbm38-eIF4E Complex with a Synthetic Peptide Pep8 Increases p53 Expression.

  2019cites this paper
• The Role of Androgen Receptor Signaling in Ovarian Cancer

  2019cites this paper
• Structural basis for the design of allosteric inhibitors of the Aurora kinase A enzyme in the cancer chemotherapy.

  2019cites this paper
• Characteristics of in Vivo Model Systems for Ovarian Cancer Studies

  2019cites this paper
• Aurora kinase A induces chemotherapy resistance through revival of dormant cells in laryngeal squamous cell carcinoma

  2019cites this paper
• Impact of AIB1 expression on the prognosis of upper tract urothelial carcinoma after radical nephroureterectomy

  2019cites this paper
• Hyperactivation of nuclear receptor coactivators induces PERK-dependent cell death

  2018cites this paper
• Identifying genes as potential prognostic indicators in patients with serous ovarian cancer resistant to carboplatin using integrated bioinformatics analysis

  2018cites this paper
• A phase 1, first-in-human study of AMG 900, an orally administered pan-Aurora kinase inhibitor, in adult patients with advanced solid tumors

  2018cites this paper
• AGBL2 promotes cancer cell growth through IRGM-regulated autophagy and enhanced Aurora A activity in hepatocellular carcinoma.

  2018cites this paper
• MuvB: A Key to Cell Cycle Control in Ovarian Cancer

  2018cites this paper
• Prognostic value of AIB1 and EIF5A2 in intravesical recurrence after surgery for upper tract urothelial carcinoma

  2018cites this paper
• PTP1B markedly promotes breast cancer progression and is regulated by miR‐193a‐3p

  2018cites this paper
• Mechanisms of B-Myb oncogenicity in ovarian cancer

  2018cites this paper
• MYBL2 (B-Myb): a central regulator of cell proliferation, cell survival and differentiation involved in tumorigenesis

  2017cites this paper
• Proteasome dysregulation in human cancer: implications for clinical therapies

  2017cites this paper
• Inhibition of Aurora Kinase A Synergistically Enhances Cytotoxicity in Ovarian Clear Cell Carcinoma Cell Lines Induced by Cisplatin: A Potential Treatment Strategy

  2017cites this paper
• Aurora A Kinase Is a Priority Pharmaceutical Target for the Treatment of Cancers.

  2017cites this paper
• Topoisomerase I copy number alterations as biomarker for irinotecan efficacy in metastatic colorectal cancer

  2017cites this paper
• Aurora A kinase regulates non-homologous end-joining and poly(ADP-ribose) polymerase function in ovarian carcinoma cells

  2017cites this paper
• Clinicopathologic features and prognostic implications of MYBL2 protein expression in pancreatic ductal adenocarcinoma.

  2017cites this paper
• Gene expression profiles of CYP24A1 and CYP27B1 in malignant and normal breast tissues.

  2017cites this paper
• Quinlan, K

  2017cites this paper
• Association between the functional polymorphism Ile31Phe in the AURKA gene and susceptibility of hepatocellular carcinoma in chronic hepatitis B virus carriers

  2017cites this paper
• The role of eukaryotic translation initiation factor 6 in tumors

  2017cites this paper
• RAC3 influences the chemoresistance of colon cancer cells through autophagy and apoptosis inhibition

  2017cites this paper
• Endothelial protein C receptor is overexpressed in colorectal cancer as a result of amplification and hypomethylation of chromosome 20q

  2017cites this paper
• Étude du rôle de la kinase Aurora-A dans le développement de la larve et du cerveau de Drosophila melanogaster

  2017cites this paper
• FUNCTIONAL REGULATION OF YAP BY AURORA A KINASE IN TRIPLE-NEGATIVE BREAST CANCER

  2016cites this paper
• Characterizing Genetic Transitions of Copy Number Alterations and Allelic Imbalances in Oral Tongue Carcinoma Metastasis

  2016cites this paper
• Aurora kinase A revives dormant laryngeal squamous cell carcinoma cells via FAK/PI3K/Akt pathway activation

  2016cites this paper
• Study of the S427G polymorphism and of MYBL2 variants in patients with acute myeloid leukemia

  2016cites this paper
• Identification and validation of AIB1 and EIF5A2 for noninvasive detection of bladder cancer in urine samples

  2016cites this paper
• MLN-8237: A dual inhibitor of aurora A and B in soft tissue sarcomas

  2016cites this paper
• Satellite Cells in Muscular Dystrophy - Lost in Polarity.

  2016cites this paper
• A Systems Biology Comparison of Ovarian Cancers Implicates Putative Somatic Driver Mutations through Protein-Protein Interaction Models

  2016cites this paper
• Secretory leukocyte protease inhibitor is a survival and proliferation factor for castration-resistant prostate cancer

  2016cites this paper
• Moving Beyond the Androgen Receptor (AR): Targeting AR-Interacting Proteins to Treat Prostate Cancer

  2016cites this paper
• RNA-binding protein RBM 38 : acting as a tumor suppressor in colorectal cancer

  2016cites this paper
• Effect of AURKA Gene Expression Knockdown on Angiogenesis and Tumorigenesis of Human Ovarian Cancer Cell Lines

  2016cites this paper
• Grb7 gene amplification and protein expression by FISH and IHC in ovarian cancer.

  2015cites this paper
• Molecular aspects of bovine cystic ovarian disease pathogenesis.

  2015cites this paper
• Integrative genomic analyses of the RNA-binding protein, RNPC1, and its potential role in cancer prediction.

  2015cites this paper
• Frequent amplification of AIB1, a critical oncogene modulating major signaling pathways, is associated with poor survival in gastric cancer

  2015cites this paper
• A gene-set approach to analyze copy number alterations in breast cancer

  2015cites this paper
• Aurora kinase A in gastrointestinal cancers: time to target

  2015cites this paper
• Promotive role of recombinant HE4 protein in proliferation and carboplatin resistance in ovarian cancer cells.

  2015cites this paper
• Antitumour activity of AMG 900 alone or in combination with histone deacetylase inhibitor SaHa on medulloblastoma cell lines

  2015cites this paper
• MiR-203 Suppresses ZNF217 Upregulation in Colorectal Cancer and Its Oncogenicity

  2015cites this paper
• The Non-Canonical Role of Aurora-A in DNA Replication

  2015cites this paper
• Implication of CYP24A1 splicing in breast cancer.

  2014cites this paper
• Role of Prolactin and Prolactin Receptor Signaling in Colorectal Tumorigenesis

  2014cites this paper
• Cause and consequence of cancer/testis antigen activation in cancer.

  2014cites this paper
• Hypoxia-inducible factor 1 alpha is regulated by RBM38, a RNA-binding protein and a p53 family target, via mRNA translation

  2014cites this paper
• Steroid Receptor Coactivators (SRCs) as Integrators of Multiple Signaling Pathways in Cancer Progression

  2014cites this paper
• Abnormal gene expression and gene fusion in lung adenocarcinoma with high-throughput RNA sequencing

  2014cites this paper
• ZNF217 is associated with poor prognosis and enhances proliferation and metastasis in ovarian cancer.

  2014cites this paper
• NCOA 1 Directly Targets M-CSF 1 Expression to Promote Breast Cancer Metastasis

  2014cites this paper
• P21-Activated Kinase 7 Mediates Cisplatin-Resistance of Esophageal Squamous Carcinoma Cells with Aurora-A Overexpression

  2014cites this paper
• Differential regulation of IRESs in the Aurora A mRNA by bFGF through the mTOR complex TORC2 modulates Aurora A kinase expression

  2014cites this paper
• NCOA1 Directly Targets M-CSF1 Expression to Promote Breast Cancer Metastasis.

  2014cites this paper
• Expression of the Microtubule-Associated Protein MAP9/ASAP and Its Partners AURKA and PLK1 in Colorectal and Breast Cancers

  2014cites this paper
• Identification of Verrucarin A as a Potent and Selective Steroid Receptor Coactivator-3 Small Molecule Inhibitor

  2014cites this paper
• Estudio de las alteraciones genéticas en adenocarcinomas gástricos mediante aCGH y FISH en su contexto clínico-patológico

  2014cites this paper
• Cancer Metastasis NCOA 1 Directly Targets M-CSF 1 Expression to Promote Breast

  2014cites this paper
• RNA-binding protein RNPC1: acting as a tumor suppressor in breast cancer

  2014cites this paper
• Molecular and Cellular Pathobiology NCOA 1 Directly Targets M-CSF 1 Expression to Promote Breast Cancer Metastasis

  2014cites this paper
• QUINASES EM CARCINOMA DE ADRENAL

  2014cites this paper